Evidence map›Paper›PMID 33915775›Full record

ReviewMolecules (Basel, Switzerland)2021

Biological Effects of β-Glucans on Osteoclastogenesis.

Wataru Ariyoshi, Shiika Hara, Ayaka Koga, Yoshie Nagai-Yoshioka, Ryota Yamasaki

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Microbiota in cancer: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  5. Review
  6. Article
  7. Molecules (Basel, Switzerland) · 2024
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wataru AriyoshiDepartment of Health Promotion, Division of Infections and Molecular Biology, Kyushu Dental University, Fukuoka 803-8580, Japan.ORCID 0000-0002-6533-5683
Shiika HaraDepartment of Health Promotion, Division of Infections and Molecular Biology, Kyushu Dental University, Fukuoka 803-8580, Japan.
Ayaka KogaDepartment of Health Promotion, Division of Infections and Molecular Biology, Kyushu Dental University, Fukuoka 803-8580, Japan.
Yoshie Nagai-YoshiokaDepartment of Health Promotion, Division of Infections and Molecular Biology, Kyushu Dental University, Fukuoka 803-8580, Japan.
Ryota YamasakiDepartment of Health Promotion, Division of Infections and Molecular Biology, Kyushu Dental University, Fukuoka 803-8580, Japan.
Kyushu Dental University · JP

Funding

Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research 18K09797The Novartis Foundation (Japan) for the Promotion of Science 2921
6 · The paper itself

Abstract

Although the anti-tumor and anti-infective properties of β-glucans have been well-discussed, their role in bone metabolism has not been reviewed so far. This review discusses the biological effects of β-glucans on bone metabolisms, especially on bone-resorbing osteoclasts, which are differentiated from hematopoietic precursors. Multiple immunoreceptors that can recognize β-glucans were reported to be expressed in osteoclast precursors. Coordinated co-stimulatory signals mediated by these immunoreceptors are important for the regulation of osteoclastogenesis and bone remodeling. Curdlan from the bacterium

Indexed as

AnimalsBone and BonesBone RegenerationBone ResorptionCartilageCell DifferentiationGlucansHumansImmunomodulationOsteoclastsOsteogenesisReceptors, ImmunologicGlucansReceptors, Immunologicbone metabolismimmunoreceptorsosteoclastogenesisβ-glucans

Identifiers

PMID33915775
PMCPMC8036280
OpenAlexW3139748510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.